Four more Vemlidy latecomers will be entering the market. Currently, only 3 products by Dong-A ST, Daewoong Pharmaceutical, and Chong Kun Dang are available in the market. Its original drug is Gilead Science Korea’s Vemlidy Tab.

According to industry sources on the 25th, Samjin Pharm, Korea Hutex Pharma, Samil Pharm, and Dongkook Pharmaceutical’s tenofovir alafenamide hemimalte hepatitis B treatments will be reimbursed from July.

The latecomers are all incrementally modified drugs that were developed with different salt formations than the original Vemlidy’s tenofovir ala fenamide hemitartar hydrochloride. Four companies have succeeded in avoiding Vemlidy’s salt patent with their sa